https://scholars.lib.ntu.edu.tw/handle/123456789/641616
標題: | Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials | 作者: | Wong, Tien Y Haskova, Zdenka Asik, Kemal Baumal, Caroline R Csaky, Karl G Eter, Nicole Ives, Jane A Jaffe, Glenn J Korobelnik, Jean-François Lin, Hugh Murata, Toshinori Ruamviboonsuk, Paisan Schlottmann, Patricio G Seres, András I Silverman, David Sun, Xiaodong Tang, Yannan Wells, John A Yoon, Young Hee Wykoff, Charles C CHANG-HAO YANG et al. |
關鍵字: | Angiopoietin-2; Diabetic macular edema; Faricimab; Vascular endothelial growth factor A; Vascular stability | 公開日期: | 2024 | 來源出版物: | Ophthalmology | 摘要: | To evaluate the 2-year efficacy, durability, and safety of dual angiopoietin-2 and vascular endothelial growth factor (VEGF) A pathway inhibition with intravitreal faricimab according to a personalized treat-and-extend (T&E)-based regimen with up to every-16-week dosing in the YOSEMITE and RHINE (ClinicalTrials.gov identifiers, NCT03622580 and NCT03622593, respectively) phase 3 trials of diabetic macular edema (DME). |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/641616 | ISSN: | 01616420 | DOI: | 10.1016/j.ophtha.2023.12.026 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。